PURCHASE FLUADPURCHASE FLUAD: flu.seqirus.com
Burden Burden

The burden of influenza
in adults 65+

As people age, their immune system ages, too. Adults over the age of 65 may experience worse outcomes in response to influenza infection due to age-related weakening of their immune systems.1,2 These changes impair the body’s ability to respond to new antigens.1 Another consequence is impaired long-term immune responses, resulting in a shorter duration of protection.1

The grim statistics: In the 2014-2015 flu season, the flu-related hospitalization rate among adults aged 65 years and older was the highest ever recorded by the CDC since it began tracking that data in 2005.3 Over the last several years, A/H3N2 strains have accounted for the majority of influenza A infections, and are the most common cause of influenza-related hospitalizations and deaths in adults 65+.4-9 Also, patients with comorbid conditions like diabetes, heart failure, asthma, and COPD have a higher risk of experiencing flu-related complications as well as potentially making their existing conditions worse.10 These reasons underscore the need for an influenza vaccine that helps deliver strong immunological protection for this vulnerable population.9

It’s important to encourage your patients to get vaccinated. Now there is a new flu vaccine, FLUAD, that helps provide a strong immune response to influenza vaccination in adults aged 65 years and older.11,a Read on to learn more about the immunogenicity and safety of FLUAD, and how it may help protect your patients.

a Like all vaccines, FLUAD may not be protective in everyone who receives it.

Each year in the US, flu-related illness in adults aged 65 years and older accounts for:

As people age, their immune system ages, too. Adults over the age of 65 may experience worse outcomes in response to influenza infection due to age-related weakening of their immune systems.1,2 These changes impair the body’s ability to respond to new antigens.1 Another consequence is impaired long-term immune responses, resulting in a shorter duration of protection.1

The grim statistics: In the 2014-2015 flu season, the flu-related hospitalization rate among adults aged 65 years and older was the highest ever recorded by the CDC since it began tracking that data in 2005.3

Each year in the US, flu-related illness in adults aged 65 years and older accounts for:

Advertisement

Over the last several years, A/H3N2 strains have accounted for the majority of influenza A infections, and are the most common cause of influenza-related hospitalizations and deaths in adults 65+.4-9

Also, patients with comorbid conditions like diabetes, heart failure, asthma, and COPD have a higher risk of experiencing flu-related complications as well as potentially making their existing conditions worse.10 These reasons underscore the need for an influenza vaccine that helps deliver strong immunological protection for this vulnerable population.9

It’s important to encourage your patients to get vaccinated. Now there is a new flu vaccine, FLUAD, that helps provide a strong immune response to influenza vaccination in adults aged 65 years and older.11,a Read on to learn more about the immunogenicity and safety of FLUAD, and how it may help protect your patients.

a Like all vaccines, FLUAD may not be protective in everyone who receives it.

 

 
 
 
 
Advertisement